Related references
Note: Only part of the references are listed.Immunotherapeutic approaches for cancer therapy: An updated review
Tohid Kazemi et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2016)
Integrative functional genomics of breast cancer
Richard Marcotte et al.
CANCER RESEARCH (2015)
Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade
Wade T. Iams et al.
CLINICAL CANCER RESEARCH (2015)
The role of the insulin-like growth factor-1 system in breast cancer
Panagiotis F. Christopoulos et al.
MOLECULAR CANCER (2015)
FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells
LaTonia Taliaferro-Smith et al.
ONCOTARGET (2015)
Role of IGF1R in breast cancer subtypes, sternness, and lineage differentiation
Susan M. Farabaugh et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Cross-talk between adiponectin and IGF-IR in breast cancer
Loredana Mauro et al.
FRONTIERS IN ONCOLOGY (2015)
Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients
Sandra Heskamp et al.
PLOS ONE (2015)
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
Sahitya K. Denduluri et al.
GENES & DISEASES (2015)
Insulin-Like Growth Factor-1 Receptor Signaling Increases the Invasive Potential of Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer Cells via Src-Focal Adhesion Kinase and Forkhead Box Protein M1
Eduardo Sanabria-Figueroa et al.
MOLECULAR PHARMACOLOGY (2015)
Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
M. Arnedos et al.
ANNALS OF ONCOLOGY (2014)
Prolyl-4-hydroxylase a subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition
Gaofeng Xiong et al.
BMC CANCER (2014)
Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer
Martin Sjostrom et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells
M. Mancini et al.
BRITISH JOURNAL OF CANCER (2014)
Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy
Jennifer Wu et al.
CANCER AND METASTASIS REVIEWS (2014)
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
Daruka Mahadevan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts
Paola De Marco et al.
ENDOCRINE-RELATED CANCER (2014)
Positive Expression of Insulin-Like Growth Factor-1 Receptor Is Associated with a Positive Hormone Receptor Status and a Favorable Prognosis in Breast Cancer
Su-Jin Shin et al.
JOURNAL OF BREAST CANCER (2014)
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
Claire Corcoran et al.
MOLECULAR CANCER (2014)
Superior Antitumor Activity of a Novel Bispecific Antibody Cotargeting Human Epidermal Growth Factor Receptor 2 and Type I Insulin-like Growth Factor Receptor
Chao Chen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen
T. Winder et al.
PHARMACOGENOMICS JOURNAL (2014)
Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
Shuying Liu et al.
ONCOTARGET (2014)
The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells
Roberta Malaguarnera et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Biology of the estrogen receptor, GPR30, in triple negative breast cancer
Jennifer Steiman et al.
AMERICAN JOURNAL OF SURGERY (2013)
Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
Ping Li et al.
BMC CANCER (2013)
β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1
Hira Lal Goel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Insulin-like growth factor-I regulates GPER expression and function in cancer cells
P. De Marco et al.
ONCOGENE (2013)
Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis
Sandra M. Saldana et al.
PLOS ONE (2013)
The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors
Wen-Wei Chang et al.
BREAST CANCER RESEARCH (2013)
MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor
Ke Shen et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
Rinat Yerushalmi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy
Rainer Girgert et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment
Dedra H. Fagan et al.
CANCER RESEARCH (2012)
Targeting insulin-like growth factor in breast cancer therapeutics
Michalis V. Karamouzis et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
The role of the insulin-like growth factor-I receptor in malignancy: An update
Erica Seccareccia et al.
GROWTH HORMONE & IGF RESEARCH (2012)
Targeting Insulin and Insulin-Like Growth Factor Signaling in Breast Cancer
Yuzhe Yang et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model
Tiphanie Durfort et al.
PLOS ONE (2012)
BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site
H. J. Kang et al.
CELL DEATH & DISEASE (2012)
Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer
A. Kolacinska et al.
NEOPLASMA (2012)
Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma
Hermien Hartog et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer
Atanas Ignatov et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
Jin Gao et al.
CANCER RESEARCH (2011)
Dual IGF-1R/InsR Inhibitor BMS-754807 Synergizes with Hormonal Agents in Treatment of Estrogen-Dependent Breast Cancer
Xiaonan Hou et al.
CANCER RESEARCH (2011)
The type 1 insulin-like growth factor receptor and resistance to DACH1
Tiziana DeAngelis et al.
CELL CYCLE (2011)
Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of ErbB2/IGF-1 receptor interactions
Bolin Liu et al.
CELL CYCLE (2011)
High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR Therapy
Beate C. Litzenburger et al.
CLINICAL CANCER RESEARCH (2011)
Minireview: IGF, Insulin, and Cancer
Emily J. Gallagher et al.
ENDOCRINOLOGY (2011)
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer
Chenfang Zhu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
The IGF Pathway Regulates ERα through a S6K1-Dependent Mechanism in Breast Cancer Cells
Marc A. Becker et al.
MOLECULAR ENDOCRINOLOGY (2011)
Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
Jaime Guevara-Aguirre et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
Razelle Kurzrock et al.
CLINICAL CANCER RESEARCH (2010)
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M. Carboni et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Jennifer H. Law et al.
CANCER RESEARCH (2008)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
The Type 1 Insulin-Like Growth Factor Receptor Pathway
Meenali M. Chitnis et al.
CLINICAL CANCER RESEARCH (2008)
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Montserrat Garcia-Closas et al.
PLOS GENETICS (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations
Sharon Maor et al.
CANCER LETTERS (2007)
Mechanisms of disease: signaling of the insulin-like growth factor I receptor pathway-therapeutic perspectives in cancer
Yungan Tao et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism
D. Cosaceanu et al.
ONCOGENE (2007)
Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation
R. A. Jones et al.
ONCOGENE (2007)
Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: Implications for cancer therapy
Donghua Yin et al.
CLINICAL CANCER RESEARCH (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Estrogen receptor regulates insulin-like growth factor-1 receptor gene expression in breast tumor cells: involvement of transcription factor Sp1
Sharon Maor et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor
JM Knowlden et al.
ENDOCRINOLOGY (2005)
Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871
BD Cohen et al.
CLINICAL CANCER RESEARCH (2005)
A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells
D Sachdev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The insulin like growth factor-1 receptor (IGF-1R) as a drug target:: novel approaches to cancer therapy
C Bähr et al.
GROWTH HORMONE & IGF RESEARCH (2004)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Iα
BL Brockdorff et al.
ENDOCRINE-RELATED CANCER (2003)
The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance
JM Gross et al.
CANCER AND METASTASIS REVIEWS (2003)
BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene
S Abramovitch et al.
FEBS LETTERS (2003)
Insulin-like growth factors and cancer
G Fürstenberger et al.
LANCET ONCOLOGY (2002)
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells
B Wen et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
